Literature DB >> 8529036

Physiological significance of plasma sulfoconjugated dopamine: experimental and clinical studies.

M Yoshizumi1, Y Ishimura, Y Masuda, T Ohuchi, I Katoh, H Houchi, M Oka.   

Abstract

Sulfoconjugated catecholamines have been regarded simply as metabolites of free catecholamines. However, a conjugated form of the catecholamine, dopamine has recently attracted much attention because it is present at high levels in the plasma of humans and experimental animals. We carried out experimental and clinical studies to determine the physiological significance of this large amount of dopamine conjugate in the plasma. Clinical studies showed that the plasma level of dopamine sulfate decreased significantly during the acute phase of heart failure, whereas that of free dopamine increased. Moreover, the plasma level of conjugated dopamine in patients with essential hypertension was higher than that in control subjects, and being highest in patients with renal hypertension. In experimental studies, we examined the activity for deconjugating DA sulfate in homogenates of organs from dogs. The kidney and liver exhibited the highest activities, and in the heart, the activity was higher in the atrium than the ventricle. We also examined the effect of dopamine sulfate on isolated perfused rat heart. Dopamine sulfate was found to be converted to free dopamine, which was responsible for the positive inotropic action, in atrial tissue. Moreover, deconjugation of DA sulfate to the free form was accelerated by a high work lord on the heart. From these results, we conclude that the formation of dopamine sulfate plays a role in regulating the level of plasma free dopamine and that plasma dopamine sulfate may be a storage or reserve form of dopamine. Free (or active) dopamine may be formed through a deconjugation reaction when necessary.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8529036     DOI: 10.1291/hypres.18.supplementi_s101

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  3 in total

1.  Tetrahydrobiopterin regulates monoamine neurotransmitter sulfonation.

Authors:  Ian Cook; Ting Wang; Thomas S Leyh
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

2.  Dopaminergic control of renal tubular function in patients with compensated cirrhosis.

Authors:  Giovanni Sansoè; Alberto Ferrari; Enrica Baraldi; Carmen Nives Castellana; Alessandra Biava; Stefano Silvano; Floriano Rosina; Lorenzo Bonardi; Federico Manenti
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

3.  Changes in plasma free and sulfoconjugated dopamine in patients with congenital heart disease who underwent cardiac operation.

Authors:  M Yoshizumi; T Kitagawa; Y Masuda; T Hori; T Kitaichi; Y Ogawa; I Katoh; H Houchi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.